---
title: "AbCellera Biologics to Present at Major Investor Conferences"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/275656787.md"
datetime: "2026-02-11T21:06:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275656787.md)
  - [en](https://longbridge.com/en/news/275656787.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275656787.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/275656787.md) | [English](https://longbridge.com/en/news/275656787.md)


# AbCellera Biologics to Present at Major Investor Conferences

AbCellera Biologics Inc. (Nasdaq: ABCL) will participate in several upcoming investor conferences in March and April 2026. The company is scheduled to present at the TD Cowen 46th Annual Health Care Conference on March 4, 2026, the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, and the Bloom Burton & Co. Healthcare Investor Conference on April 21-22, 2026. Live audio webcasts of each presentation will be accessible through a link posted on AbCellera’s Investor Relations website closer to the date, with replays available through the same link following the presentations. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260210650979) on February 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相關股票

- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [Abcellera Biologics (ABCL.US)](https://longbridge.com/zh-HK/quote/ABCL.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)

## 相關資訊與研究

- [NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy | NRXBF Stock News](https://longbridge.com/zh-HK/news/281376637.md)
- [FDA Approves Eli Lilly's Foundayo For Adults With Obesity, Weight-Related Medical Conditions](https://longbridge.com/zh-HK/news/281395378.md)
- [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/zh-HK/news/281174211.md)
- [13:02 ETRO LAUNCHES ELI LILLY'S KWIKPEN®, OFFERING PATIENTS A MORE CONVENIENT WAY TO TAKE ZEPBOUND®](https://longbridge.com/zh-HK/news/281557703.md)
- [BUZZ-Context Therapeutics rises as FDA grants fast-track status to ovarian cancer drug](https://longbridge.com/zh-HK/news/281517197.md)